Emergent BioSolutions | Ativo Circulante





Ativo Circulante Alterar Data
Acadia Pharmaceuticals USD 1.08B 115.87M 2025-09
Akebia Therapeutics USD 258.34M 23.68M 2025-09
ALKERMES USD 1.74B 106.38M 2025-09
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Amarin USD 628.33M 21.52M 2025-09
ANI Pharmaceuticals USD 698.4M 95.77M 2025-09
BioMarin Pharmaceutical USD 3.85B 49.21M 2025-09
Coherus Biosciences USD 460.96M 80.75M 2025-09
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Exact Sciences USD 1.56B 34.88M 2025-12
Exelixis USD 1.44B 41.03M 2025-12
Glaxosmithkline GBP 23.98B 6.31B 2025-09
Heron Therapeutics USD 229.4M 18.48M 2025-09
Ionis Pharmaceuticals USD 2.52B 58.16M 2025-09
Ironwood Pharmaceuticals USD 273.84M 82.09M 2025-09
Lexicon Pharmaceuticals USD 145.08M 100.72M 2025-06
Lonza CHF 5.44B 113M 2024-12
Merck USD 47.56B 10.49B 2025-09
Moderna USD 6.54B 54M 2025-12
Myriad Genetics USD 344.8M 60.5M 2025-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Pacira USD 562.75M 182.86M 2025-09
Pfizer USD 46.92B 3.22B 2025-09
PTC Therapeutics USD 2.01B 265.07M 2025-09
Sanofi EUR 30.95B 3.09B 2025-12
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
United Therapeutics USD 3.49B 332.9M 2025-09
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12
Xoma USD 110.71M 5.78M 2025-09


Emergent BioSolutions Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.